Recombinant CTLA-4 (Ipilimumab Biosimilar) antibody
This anti-CTLA-4 (Ipilimumab Biosimilar) antibody is a Human Monoclonal antibody detecting CTLA-4 (Ipilimumab Biosimilar) in FACS, ELISA, BLI, Func and SPR. Suitable for Human.
Catalog No. ABIN7675654
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant CTLA-4 (Ipilimumab Biosimilar) antibody (ABIN7675654)
Target
CTLA-4 (Ipilimumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CTLA-4 (Ipilimumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab)
-
Characteristics
- Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.2 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
anti-CTLA-4 (Ipilimumab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- CTLA-4 (Ipilimumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.2 kDa
-
UniProt
- P16410
Target
-
You are here:
